STACIA ROYES: Open Payments
NPI 1033755962 · LINDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 20 payments from 9 companies in 2025. Trend: 2023 $601 · 2024 $850 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $285 |
| MEDICOMP INC | 2 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| CVRx, Inc. | 2 | $41 |
| Corcept Therapeutics | 2 | $35 |
| ABIOMED | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Wegovy, TELEPATCH CARDIAC MONITOR, FARXIGA, Kerendia, Barostim Neo System, Korlym, JARDIANCE, AREXVY.
Industry payments across NJ — which companies pay providers there.
